Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Signorovitch

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Cancer Medicine|December 22, 2015
Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician surveyPeggy L Lin, Yanni Hao, Jipan Xie, et al.
Current Medical Research and Opinion|June 16, 2015
Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancerNanxin Li, Yanni Hao, Jipan Xie, et al.
Pediatric Pulmonology|August 5, 2011
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solutionGregory S Sawicki, James E Signorovitch, Jie Zhang, et al.
Current Medical Research and Opinion|April 6, 2018
Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysisApril W Armstrong, Keith A Betts, James E Signorovitch, et al.
Advances in Therapy|September 14, 2018
Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United StatesSunnie Kim, James E Signorovitch, Hongbo Yang, et al.
Current Medical Research and Opinion|February 23, 2012
Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysisJames E Signorovitch, Thomas M Samuelson, Karthik Ramakrishnan, et al.
Applied Health Economics and Health Policy|November 2, 2012
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonM Haim Erder, Jipan Xie, James E Signorovitch, et al.
Current Medical Research and Opinion|October 29, 2014
Treatment patterns and duration in post-menopausal women with HR+/HER2- metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004-2010)Alexander R Macalalad, Yanni Hao, Peggy L Lin, et al.
Clinical Genitourinary Cancer|December 29, 2015
Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart ReviewsSumanta K Pal, James E Signorovitch, William M Reichmann, et al.
Current Medical Research and Opinion|October 31, 2014
One-year and long-term molecular response to nilotinib and dasatinib for newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparisonJames E Signorovitch, Keith A Betts, William M Reichmann, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Cancer Medicine|December 22, 2015
Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician surveyPeggy L Lin, Yanni Hao, Jipan Xie, et al.
Current Medical Research and Opinion|June 16, 2015
Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancerNanxin Li, Yanni Hao, Jipan Xie, et al.
Pediatric Pulmonology|August 5, 2011
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solutionGregory S Sawicki, James E Signorovitch, Jie Zhang, et al.
Current Medical Research and Opinion|April 6, 2018
Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysisApril W Armstrong, Keith A Betts, James E Signorovitch, et al.
Advances in Therapy|September 14, 2018
Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United StatesSunnie Kim, James E Signorovitch, Hongbo Yang, et al.
Current Medical Research and Opinion|February 23, 2012
Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysisJames E Signorovitch, Thomas M Samuelson, Karthik Ramakrishnan, et al.
Applied Health Economics and Health Policy|November 2, 2012
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonM Haim Erder, Jipan Xie, James E Signorovitch, et al.
Current Medical Research and Opinion|October 29, 2014
Treatment patterns and duration in post-menopausal women with HR+/HER2- metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004-2010)Alexander R Macalalad, Yanni Hao, Peggy L Lin, et al.
Clinical Genitourinary Cancer|December 29, 2015
Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart ReviewsSumanta K Pal, James E Signorovitch, William M Reichmann, et al.
Current Medical Research and Opinion|October 31, 2014
One-year and long-term molecular response to nilotinib and dasatinib for newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparisonJames E Signorovitch, Keith A Betts, William M Reichmann, et al.
Pageof 5